Dexamethasone Sodium Phosphate Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Dexamethasone Sodium Phosphate Injection (injection) from Fresenius Kabi USA, LLC with status No longer listed by FDA. The shortage was first posted on Feb 8, 2019. Reported reason: Demand increase for the drug
Shortage details
- Status
- No longer listed by FDA
- Company
- Fresenius Kabi USA, LLC
- Package NDC
- 76045-106-10
- Dosage Form
- Injection
- Presentation
- Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 76045-106-10)
- Initial Posting
- Feb 8, 2019
Reason
Demand increase for the drug